Dermatology Times recently interviewed renowned dermatologist Dr. Dendy Engelman about why she decided to incorporate EVERESSE monopolar RF into her practice. Below is an excerpt from How EVERESSE Monopolar RF is Revolutionizing Patient Care, According to Dendy Engelman, MD, FACMS, FAAD, co-written by Marie Bosslet and Dr. Engelman.
New offering enables faster, non-invasive skin tightening for the body with visible results.
HOLA!, the leading US celebrity and culture publication, recently covered a new viral beauty trend of wearing face shapewear. In this article, Dr. Dendy Engelman shares what's a gimmick -- and what works. Below is an excerpt highlighting EVERESSE from Anthony Hopkins pokes fun at Kim Kardashian's face shapewear: Experts reveal if this is another...
EVERESSE was chosen as one of the winners from ELLE's second annual Tools and Treatments Awards, which honors the best in-home gadgets and in-office treatments reviewed and tested by the staff at ELLE. Below is an excerpt from The 23 Best In-Office Treatments to Sculpt, Lift, and Enhance, written by Kathleen Hou, Katie Berohn and Tasha Nicole...
Discover how devices like SKNLAB, Everesse, Prisma & Motus support skin longevity by stimulating collagen production and promoting skin revitalization at multiple levels.
Four new technologies make their debut in Q2 2025, expanding access to advanced aesthetic treatments in North America
EVERESSE by Volnewmer, the cutting-edge RF technology created by global aesthetics leader Classys, was recently featured in the March/April 2025 issue of The Aesthetic Guide. Below is an excerpt from Monopolar RF Devices Adds Volume to Skin Tightening Benefits, written by Lisette Hilton. Read more in the March/April issue of The Aesthetic Guide,...
In today's aesthetics environment, a noticeable shift is underway. Clients who once enthusiastically embraced dermal fillers are now experiencing what industry professionals call "filler fatigue"—a growing dissatisfaction with repeated injections, often unnatural results, and longer-term residual effects.
The popularity of GLP-1 and GIP medications, such as Ozempic and Mounjaro, have significantly reshaped the aesthetics industry. As these medications become more widely adopted and accessible, more patients than ever are experiencing rapid weight loss—and its accompanying aesthetic changes. This widespread use has given rise to what experts call...
In the evolving field of aesthetic treatments, patients increasingly seek non-invasive solutions that deliver natural-looking results without compromising efficacy or comfort. Enter EVERESSE, a groundbreaking monopolar RF device that represents the next evolution in non-invasive technology.
Despite a tough economic environment in 2024, aesthetics consumers continued to spend – and they’re not planning to stop in 2025. According to research from NewBeauty, the majority of consumers plan to maintain the same level of spending on aesthetics treatments; even if they had to reduce their overall spending, they’re much more likely to cut...
Classys, Inc. recently spoke at the 2025 J.P. Morgan Healthcare Conference, highlighting their long-term growth and expansion plans in the U.S. and Europe, including their new partnership with Cartessa to bring EVEREVESSE by Volnewmer to the U.S. market. Below is an excerpt from Classys Details US Expansion and European Launch Plans at JPM2025, as...
Cartessa's launch of EVERESSE, the monopolar RF device created by Classys, was recently covered by MedEsthetics Mag. Below is an excerpt from Cartessa Aesthetics Introduces Classys' Everesse to US Skin Tightening & Rejuvenation Market.
Classys, Inc. and Cartessa Aesthetics' recent partnership announcement was featured in Korea Biomedical Review. Below is an excerpt from Classys and Cartessa Launch Anti-Aging Device in US.
Everesse Monopolar RF technology overcomes shortcomings of legacy devices to effectively and comfortably lift and volumize the skin.
